Insulin Infusion therapy in critical care patients: regular insulin VS. short acting insulin. A prospective, crossover, randomized, multicenter blind study

The aim of this multicenter, prospective, randomized, crossover trial is to compare, in critical care patients receiving insulin infusion therapy (IIT), the pharmacodynamic of Humulin insulin (Hlin), currently used as “standard of care”, and Humalog insulin (Hlog), a shorter acting insulin formulation. This was measured as extent and duration of the carryover effect of insulin treatment, with the latter calculated as ratio between blood glucose concentration (BGC) reduction during and after IIT.
Source: Journal of Critical Care - Category: Intensive Care Authors: Source Type: research